Call for expression of interest in membership of the Scientific Committee of the European Union Drugs Agency (EUDA)

Call for scientists - Join the EUDA Scientific Committee, Deadline: 17.01.2024
This call is addressed to scientists who wish to be considered for membership of the European Union Drugs Agency (EUDA) Scientific Committee.

About EUDA

On 2 July 2024, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will become the European Union Drug Agency (EUDA) in accordance with Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006. 

The European Union Drugs Agency (EUDA), based in Lisbon, Portugal, was established to provide the Union and the Member States with

  1. factual, objective, reliable and comparable information, early warning and risk assessment at Union level concerning drugs, drug use, drug use disorders and addictions, prevention, treatment, care, risk and harm reduction, rehabilitation, social reintegration, recovery, drug markets and supply, including illicit production and trafficking, and other relevant drug-related issues and their consequences;
  2. and recommend appropriate and concrete evidence-based actions on how to address, in an efficient and timely manner, the challenges relating to drugs, drug use, drug use disorders and addictions, prevention, treatment, care, risk and harm reduction, rehabilitation, social reintegration, recovery, drug markets and supply, including illicit production and trafficking, and other relevant drug-related issues and their consequences.

For additional information on EUDA, please see New legislation grants Europe stronger powers to tackle current and future drug problems.

About the Scientific Committee

Role

The task of the Scientific Committee is to assist the Management Board and the Executive Director of the EUDA by delivering an opinion on any scientific matter concerning the Agency's activity which the Management Board or the Executive Director may submit to it.

 In addition, the risk assessment of new psychoactive substances is also carried out by the Scientific Committee. In carrying out the risk assessment of new psychoactive substances, the Scientific Committee can be extended by including experts representing the scientific fields relevant for ensuring a balanced assessment of the risks posed by the new psychoactive substance or the group of new psychoactive substances.

Composition

The Scientific Committee consists of no less than seven and no more than 15 scientists appointed by the Management Board in view of their scientific excellence in relation to the fields of the mandate of the EUDA and their independence. They shall be appointed for four-year period, which shall be renewable once, in a personal capacity, shall give their opinions completely independently of the Member States and the European Union Institutions and shall act in the public interest. They shall neither seek nor take instructions from any government or from any other body.

They shall possess proven scientific excellence, both in terms of experience and expertise, in relation to the fields of the mandate of the EUDA, namely:

  • Basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research, pharmacology and toxicology)
  • Population-based research and epidemiology (including surveys and ethnographic studies)
  • Demand reduction and public health (including prevention, treatment, harm reduction and reintegration)
  • Supply, supply reduction and crime
  • Drug policy (including laws, economic issues and strategies)
  • Analytical/forensic chemistry
  • Research and/or evaluation methods

Meetings

Meetings of the Scientific Committee are generally held twice a year at the EUDA premises in Lisbon. The vehicular working language of the Scientific Committee is English. Members are expected to attend these meetings, as well as risk assessment meetings. If a member does not attend two consecutive Scientific Committee meetings, the membership may be withdrawn.

Members of the Scientific Committee will be entitled to an indemnity for each meeting day. Members will also receive travel and subsistence allowance in accordance with the EUDA’s policy for the reimbursement of travel and accommodation expenses.

Declarations of independence and interest

Upon appointment, each member of the EUDA Scientific Committee shall sign a declaration of independence in relation to the performance of his/her duties in and for this body and shall fill in and sign a written declaration of interest covering current and past interests up to five years before the date of the declaration. These declarations will be made available for public scrutiny on the EUDA website, with due respect to EU rules on protection of personal data.

Eligibility requirements, selection procedure, and how to apply

Requirements for eligibility

By the deadline for submission of applications, candidates must have:

  1. A University degree in a relevant scientific area. An academic education of postgraduate level will be considered as an asset;
  2. Seven years of experience after obtaining the above mentioned degree;
  3. Nationality of one of the EU Member States, Türkiye or Norway.

Supporting documents

Please read carefully the complete information on this call:

How to apply

Complete and submit the application form.

Closing date

The closing date for submission of applications is 17.01.2024 at 23h59, Lisbon time. The EMCDDA/EUDA reserves the right to disregard any expressions of interest sent after that date.

Top